RecruitingNCT07510087
Glaucoma Related Quality of Life
Sponsor
Marc Toeteberg-Harms
Enrollment
5,000 participants
Start Date
Dec 30, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
Subjects with a diagnosis of glaucoma will be handed out different quality of life related questionnaires and their score will be evaluated at baseline and 3-6 months after treatment or surgery was initiated/performed.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- diagnosis of glaucoma
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERGQL-15
GQL-15 questionnaire
OTHERGlaucoma Symptom Scale
GSS questionnaire
OTHERNEI Vision Function Questionnaire
Vision function questionnaire
OTHEROcular Surface Disease Index
OSDI questionnaire
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07510087
Related Trials
Efficacy and Safety of the ELIOS Laser in Combined Cataract and Glaucoma Surgery
NCT067601691 location
Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension
NCT0716890214 locations
Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
NCT074958521 location
A Trial of Hydrus Microstent Versus Goniotomy
NCT062894911 location
Advancing Pediatric Retinal Imaging With Auto-aligned OCT
NCT068415751 location